| (19) |
 |
|
(11) |
EP 2 019 142 A9 |
| (12) |
CORRECTED EUROPEAN PATENT APPLICATION |
|
Note: Bibliography reflects the latest situation |
| (15) |
Correction information: |
|
Corrected version no 1 (W1 A3) |
|
Corrections, see
Bibliography |
| (48) |
Corrigendum issued on: |
|
13.05.2009 Bulletin 2009/20 |
| (88) |
Date of publication A3: |
|
01.04.2009 Bulletin 2009/14 |
| (43) |
Date of publication: |
|
28.01.2009 Bulletin 2009/05 |
| (22) |
Date of filing: 05.12.2005 |
|
| (51) |
International Patent Classification (IPC):
|
|
| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE
SI SK TR |
| (30) |
Priority: |
03.12.2004 US 632567 P
14.06.2005 US 690160 P
25.08.2005 US 710999 P
21.10.2005 US 728737 P
|
| (62) |
Application number of the earlier application in accordance with Art. 76 EPC: |
|
05852821.7 / 1824982 |
| (71) |
Applicant: Senesco Technologies, Inc. |
|
New Brunswick, NJ 08901 (US) |
|
| (72) |
Inventors: |
|
- Thompson, John, E.
Waterloo
Ontario N2K 4N1 (CA)
- McNamara, Linda
Waterloo
Ontario N2V 1C3 (CA)
- Wu, Wendy
Waterloo, Ontario N2J 1X2 (CA)
- Wang, Tzann-Wei
Waterloo, Ontario N2V 2L5 (CA)
|
| (74) |
Representative: Vossius & Partner |
|
Siebertstraße 4
81675 München
81675 München (DE) |
|
| |
|
| (54) |
Isoforms of elF-5A and methods of using same |
(57) The present invention relates to unique isoforms of eukaryotic initiation Factor
5A ("eIF-5A"): senescence-induced eIF-5A; wounding/pathogen induced eIF-5A; stress
eIF-5A and growth eIF-5A, as well as polynucleotides that encode these three factors.
The present invention also relates to methods involving modulating the expression
of these factors. The present invention also relates to deoxyhypusine synthase ("DHS"),
polynucleotides that encode DHS, and methods involving modulating the expression of
DHS.